| Noha Ghusson, MD | |
|
40 Fuld St Ste 305, Trenton, NJ 08638-5247 | |
| (609) 394-6338 | |
| (609) 394-6328 |
| Full Name | Noha Ghusson |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 10 Years |
| Location | 40 Fuld St Ste 305, Trenton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902225683 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 25MA10208000 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Regional Medical Center | Trenton, NJ | Hospital |
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Medical Group | 7618264532 | 364 |
News Archive
When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.
HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.
When a particular combination of proteins is expressed by a mother and her developing fetus, the risk of developing preeclampsia increases, according to a study by Hiby and colleagues in the Oct 18 issue of The Journal of Experimental Medicine.
Researchers have identified specific predictive biomarkers that could help assess the level of risk for recurrence in patients with malignant glioma. The study, led by Henry Ford Health System's Department of Neurosurgery and Department of Public Health Sciences, was published today in Cell Reports.
› Verified 5 days ago
| Entity Name | Infectious Disease Center Of New Jersey, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629155429 PECOS PAC ID: 9638177900 Enrollment ID: O20061121000054 |
News Archive
When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.
HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.
When a particular combination of proteins is expressed by a mother and her developing fetus, the risk of developing preeclampsia increases, according to a study by Hiby and colleagues in the Oct 18 issue of The Journal of Experimental Medicine.
Researchers have identified specific predictive biomarkers that could help assess the level of risk for recurrence in patients with malignant glioma. The study, led by Henry Ford Health System's Department of Neurosurgery and Department of Public Health Sciences, was published today in Cell Reports.
› Verified 5 days ago
| Entity Name | Capital Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20160921000449 |
News Archive
When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.
HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.
When a particular combination of proteins is expressed by a mother and her developing fetus, the risk of developing preeclampsia increases, according to a study by Hiby and colleagues in the Oct 18 issue of The Journal of Experimental Medicine.
Researchers have identified specific predictive biomarkers that could help assess the level of risk for recurrence in patients with malignant glioma. The study, led by Henry Ford Health System's Department of Neurosurgery and Department of Public Health Sciences, was published today in Cell Reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Noha Ghusson, MD 16 Grove Ave, Cedar Grove, NJ 07009-1452 Ph: (609) 558-4569 | Noha Ghusson, MD 40 Fuld St Ste 305, Trenton, NJ 08638-5247 Ph: (609) 394-6338 |
News Archive
When a whole country's public health is at stake, making the wrong policy choices can cost lives and money. That's why researchers have worked to develop computer simulations of epidemics that can model individual behaviors and interactions to predict the spread of disease and the efficacy of interventions.
HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.
When a particular combination of proteins is expressed by a mother and her developing fetus, the risk of developing preeclampsia increases, according to a study by Hiby and colleagues in the Oct 18 issue of The Journal of Experimental Medicine.
Researchers have identified specific predictive biomarkers that could help assess the level of risk for recurrence in patients with malignant glioma. The study, led by Henry Ford Health System's Department of Neurosurgery and Department of Public Health Sciences, was published today in Cell Reports.
› Verified 5 days ago
Dr. Abdul W Mughal, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 40 Fuld St, Suite 404, Trenton, NJ 08638 Phone: 609-394-0660 Fax: 609-394-1004 | |
Delaram Moazami, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6000 | |
Dr. Peter Anthony Ricketti, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1544 Kuser Rd Ste C6, Trenton, NJ 08619 Phone: 609-581-9900 Fax: 609-581-9905 | |
Palakkummar Ganpatbhai Patel, M.D., Infectious Disease Medicare: Medicare Enrolled Practice Location: 2312 Whitehorse Mercerville Rd Ste 105, Trenton, NJ 08619 Phone: 609-586-7400 Fax: 609-586-7656 | |
Deepika Suleria, Infectious Disease Medicare: Medicare Enrolled Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6031 | |
Dr. Khadija Baig, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6000 | |
Christine Marie Capio, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 132 Perry St, Trenton, NJ 08618 Phone: 609-394-8988 Fax: 609-394-8842 |